The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer, MD

This entry was posted in - Biotech, - Generics, FDA. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *